VTEX: BOTSMARK proposes $32,400 sale of 9,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BOTSMARK LLC, whose relationship to VTEX is listed as Officer, reports a proposed sale for its account of 9,000 common shares, with an approximate sale date of June 16, 2026 and an aggregate market value of $32,400.00. Morgan Stanley Smith Barney LLC is listed as broker. The shares were acquired from VTEX on April 29, 2020, through previously exercised stock options, with cash payment.
The listed number of VTEX common shares outstanding is 92,576,749. BOTSMARK LLC’s past-three-months sales include 1,500 shares on April 16, 2026, for gross proceeds of $6,171.00, and 1,500 shares on May 18, 2026, for gross proceeds of $5,260.05; both entries are labeled 10b5-1 sales. The stated plan adoption or instruction date is March 2, 2026.
Key Figures
Key Terms
Previously Exercised Stock Options financial
10b5-1 Sales regulatory
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent VTEX sales does BOTSMARK LLC report?
AI-generated analysis. How Rhea-AI works. Not financial advice.